Pharma major Torrent Pharmaceuticals Ltd on Tuesday reported standalone net profit of ₹168 crore for the quarter ended March 31, against ₹164 in the corresponding quarter a year ago, a growth of 2 per cent year-on-year.
Standalone revenues from operations stood at ₹1,491 crore (₹1,357 crore).
For the financial year 2019-20, the company registered standalone net profit of ₹939 crore, up 26 per cent from ₹745 crore in the previous year.
Standalone revenues from operations for the fiscal stood at ₹6,168 crore (₹5,762 crore).
The Board of Directors at its meeting held on Tuesday did not consider any further dividend for the fiscal. “The interim dividend of ₹32 (including ₹15 as special dividend) declared by the Board at its meeting held on March 11, shall be considered as final dividend for fiscal 2020,” it said in a regulatory filing.
“During these unprecedented times of the pandemic, Torrent Pharma recognises that it has an important role to play in the healthcare ecosystem and has proactively taken actions to ensure product availability and business continuity,” Samir Mehta, Chairman, Torrent Pharma said.
The company’s Q4 margins continued to benefit largely from the synergies of the acquired Unichem portfolio, incremental productivity and cost control. “Our focus continues to remain on India, US, Brazil and Germany as our core markets. For the US, remediation work at Dahej and Indrad has progressed as per plan and we expect Germany growth to revive in fiscal 2020-21,” he added.
On a consolidated basis, the company posted net profit of ₹314 crore for the quarter, against a net loss of ₹152 crore in the corresponding quarter last year. Consolidated revenues from operations stood at ₹1,946 crore (₹1,856 crore).
For fiscal 2020, company's consolidated net profit stood at ₹1,025, crore, up 135 per cent from ₹436 crore in the previous year.
A letter from the Editor
Dear Readers,
The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.
Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.
In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.
We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.
But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.
I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.
A little help from you can make a huge difference to the cause of quality journalism!
Support Quality Journalism